Resapp (RAP) applies for CE Mark in December 2018 for their devise (App) and in August 2019 (8 months) they receive their CE from BSI.
No delays. One application. No further studies. No expert opinions etc etc. All done 8MONTHS!!!
Here, almost 5 years, delays, requests, more clinical studies, rejections etc etc etc. More millions of dollars spent.
What a joke!
- Forums
- ASX - By Stock
- OSL
- CE Mark Odds
CE Mark Odds, page-42
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.78M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $116.5K | 16.65M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 12312335 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 3137908 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 12312335 | 0.006 |
22 | 16053399 | 0.005 |
33 | 25078699 | 0.004 |
9 | 11539965 | 0.003 |
6 | 5457516 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 3137908 | 9 |
0.008 | 12587076 | 12 |
0.009 | 17723395 | 9 |
0.010 | 11783000 | 9 |
0.012 | 10910 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
OSL (ASX) Chart |